The fungal pathogen Histoplasma capsulatum evades the innate and adaptive immune responses and thrives within resting macrophages. Cytokines that induce antimicrobial activity, such as granulocyte macrophage colony-stimulating factor (GM-CSF), inhibit H. capsulatum growth in macrophages. Conversely, interleukin 4 inhibits the killing of intracellular pathogens. Using inductively coupled plasma mass spectrometry, we examined alterations in the metal homeostasis of murine H. capsulatum-infected macrophages that were exposed to activating cytokines. Decreases in the levels of iron (Fe 2+ and Fe Histoplasma capsulatum infection is initiated by inhalation of fungal spores followed by conversion to the pathogenic yeast phase. The infection is controlled in most immunocompetent individuals but establishes a persistent state. Histoplasmosis can be life-threatening for individuals with immune defects arising from human immunodeficiency virus (HIV) infection or those receiving drugs for malignancy, graft rejection, or autoimmune diseases. More recently, lower levels of tumor necrosis factor a antagonists have been linked to a higher incidence of histoplasmosis [1] . Alveolar macrophages are the presumed first line of
cellular defense that H. capsulatum encounters in the host. Macrophages are the only professional phagocytic cell population in which H. capsulatum replicates freely [2] , although growth is inhibited following cytokine activation of macrophages. Interferon g (IFN-g) and granulocyte macrophage colony-stimulating factor (GM-CSF) restrict growth in mouse and human macrophages, respectively [3, 4] . One mechanism by which IFN-g inhibits H. capsulatum intracellular growth is by restricting iron [3] . Much of these data have been accrued by adding exogenous iron to cells or restricting access to iron. A missing analysis has been a direct measurement of iron or any metal present within phagocytes or pathogens harbored by these cells.
Since metals are critical to the functional integrity of cells, we sought to determine whether there was a correlation between metal uptake of H. capsulatum-infected macrophages activated by cytokines. We observed that zinc (Zn 2+ ) and total iron (Fe 2+ and Fe 3+ ) levels were restricted inside GM-CSF-treated macrophages infected with H. capsulatum compared with those inside resting macrophages. Zn 2+ binding species were differentially regulated within resting macrophages versus GM-CSF-treated cells. Chelating Zn 2+ reduced H. capsulatum growth in medium and within resting macrophages. Moreover, pretreating GM-CSF-activated macrophages with interleukin 4 (IL-4) reversed growth inhibition and partially replenished Zn 2+ levels. These data support an important role for Zn 2+ restriction as a host defense strategy against H. capsulatum infection.
METHODS
Mice. Six-to eight-week-old C57BL/6 mice were purchased from Jackson Laboratories. Animals were housed in isolator cages and maintained by the Department of Laboratory Animal Medicine, University of Cincinnati, which is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. All animal experiments were performed in accordance with the Animal Welfare Act guidelines of the National Institutes of Health. All protocols were approved by the University of Cincinnati Institutional Animal Care and Use Committee.
Reagents. Sodium dodecyl sulfate (SDS), high-performance liquid chromatography (HPLC)-grade water, methanol, diethylenetriaminepentaacetic acid (DTPA), ethylene glycol tetraacetic acid (EGTA), N,N,N ,N -tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), zinc sulfate (ZnSO 4 ), iron sulfate (FeSO 4 ), and F-12 Ham nutrient mixture were purchased from Sigma Aldrich. Recombinant mouse GM-CSF, IFN-g, and IL-4 were acquired from PeproTech. Arginase (Arg1), chitinase 3-like 3 (Chi3l3), and resistin like alpha (Retnla) primers for reversetranscription polymerase chain reaction (RT-PCR) analysis were purchased from Applied Biosystems, and TRIzol was purchased from Invitrogen. A Diff-Quik stain kit was obtained from IMEB.
All solutions for inductively coupled plasma mass spectrometry (ICPMS) analysis were prepared in 18 MQ/cm double deionized water (Sybron Barnstead), in which no metal was detected. The mobile phase for size exclusion chromatography (SEC) was made by dissolving tris(hydroxymethyl)aminomethane (Tris) in double deionized water and adjusting the pH with hydrochloric acid. The SEC standard (Bio-Rad Laboratories) is a lyophilized mixture of molecular weight markers ranging from 1300 to 670,000 Da.
H. capsulatum intracellular growth assays. Murine alveolar macrophages, bone-marrow-derived (BMD) macrophages, and peritoneal macrophages were used. Alveolar macrophages were prepared by means of consecutive lung lavages, rinsing 5 times with 1 mL of phosphate-buffered saline. Peritoneal macrophages were acquired by lavaging peritoneal cavities with 10 mL of phosphate-buffered saline. BMD macrophages were generated by extracting bone marrow cells from the femurs of mice, and cells were incubated in Roswell Park Memorial Institute (RPMI) 1640 growth medium at 37ЊC in the presence of GM-CSF at a concentration of 10 ng/mL and 5% carbon dioxide for 5-6 d. In some experiments, cells were incubated with 10 ng/mL of IL-4 for another 24 h following 5 d of incubation with GM-CSF. Peritoneal macrophages were incubated with 10 ng/mL of either GM-CSF or IFN-g for 24 h. All macrophages were plated at cells per well in a 96-well plate. 5 1 ϫ 10 H. capsulatum strain G217B yeasts were grown as described elsewhere [5] . Macrophages were infected with H. capsulatum at a multiplicity of infection (MOI) of 5 yeasts per macrophage; growth inside macrophages was quantified by plating. Infected macrophages were lysed in sterile water and lysates plated onto Mycosel agar 5 (Becton Dickinson) plates containing 5% sheep blood and 5% glucose. Plates were incubated at 30ЊC for 1 wk.
The leucine assay was used for metal chelation and supplementation experiments [4] . For metal supplementation experiments, ZnSO 4 or FeSO 4 was added at a concentration of 100 mmol/L to RPMI 1640 medium, and for metal chelation experiments, TPEN or DTPA was added prior to infection. The toxicity of TPEN, DTPA, and ZnSO 4 was measured using trypan blue stain.
Sample preparation for ICPMS analysis of infected macrophages and intracellular yeasts. Macrophages were plated at cells per well in a 12-well plate and infected with H. Yeasts and infected macrophages were further diluted at 1: 1.25 to set at a concentration of 20% nitric acid. Before ICPMS analysis of infected macrophages and isolated organisms, each sample was subjected to microwave digestion using a closedvessel Discover-Explorer microwave digestion system (CEM). The digestion process was performed at 150ЊC for 2 min by maintaining a pressure of !250 psi.
For SEC and ICPMS analysis, samples were not subjected to microwave digestion. Infected macrophages were immediately centrifuged following treatment with 0.1% SDS, and H. capsulatum was removed. The supernatant was stored at Ϫ70ЊC before ICPMS analysis.
ICPMS analysis. ICPMS-based quantification has been commonly used to determine accurate concentrations of multiple metals simultaneously in biological samples [6, 7] . ICPMS , and a shield torch constitute the sample introduction system under standard plasma conditions. HPLC was performed using flow injection, and SEC was performed with an Agilent 1100 liquid chromatograph (Agilent Technologies) equipped with a binary HPLC pump, an autosampler, a vacuum degasser system, a temperature column compartment, and a diode array detector. The outlet of the HPLC UV detector was connected to a sample inlet of the ICPMS nebulizer by use of 0.25-mm-diameter polyether ether ketone tubing of 30 cm in length. Both UV (wavelength, 280 nm) and ICPMS signals were collected online.
A Superdex 200 10/300 GL column (area, mm 2 ; 10 ϫ 300 bead size, 13 mm; Amersham Pharmacia Biotech) was used for SEC analysis. The column was calibrated with a UV detector (wavelength, 280 nm) by use of a gel filtration standard mixture (molecular weight of thyroglobulin, 670 kDa; molecular weight of g-globulin, 158 kDa; molecular weight of ovalbumin, 44 kDa; molecular weight of myoglobin, 17 kDa; molecular weight of vitamin B 12 , 1.3 kDa), which was purchased from Bio-Rad Laboratories. Lysed macrophages (treated with 0.1% SDS as described above) were injected onto the column. ICPMS flow injection analysis and SEC conditions are shown in Table 1 .
Intracellular H. capsulatum counting. The number of organisms within each cytokine-treated macrophage population after the addition of the yeasts (MOI, 5 yeasts per macrophage) was counted by staining cells with Diff-Quik and counting at least 100 infected macrophages.
Flow cytometry. Two hundred thousand macrophages were treated with IL-4 for 24 h and then exposed to H. capsulatum. Cells were then stained with peridinin chlorophyll protein complex (PerCP)-conjugated CD11b and allophycocyanin-conjugated CD71 (BD Biosciences). Cells were then stained with allophycocyanin-conjugated CD71 antibodies. Flow cytometry analysis was performed on macrophages infected with H. capsulatum (MOI, 5 yeasts per macrophage) that expressed green fluorescent protein [8] and PerCP-CD11b to determine the percentage of infected cells. Staining for both groups was performed at 4ЊC for 15 min in HBSS containing 1% bovine serum albumin and 0.01% sodium azide. Cells were washed and resuspended in 1% paraformaldehyde to fix. Isotype controls were performed in parallel. The fluorescence intensity was assessed using a FACSCalibur device (BD Biosciences) and analyzed using FCS Express software (version 3; De Novo).
Quantitative RT-PCR. A total of macrophages 5 5 ϫ 10 were infected at a MOI of 5 yeasts per macrophage. After 24 h, the total RNA from macrophages was isolated using TRIzol. Oligo(deoxythymidylic acid)-primed complementary DNA was prepared using the reverse transcriptase system (Promega). Quantitative RT-PCR analysis for was performed using TaqMan Master Mix and the following primers: hydroxyphosphoribosyl transferase (Hprt), Arg1, Retnla (Fizz1), Chi3l3 (Ym1), and calprotectin (S100). Samples were analyzed on an ABI Prism 7500 instrument (Applied Biosystems). In each experiment, Hprt was used as an internal control. The conditions for amplification were 50ЊC for 2 min, then 95ЊC for 10 min, followed by 40 cycles of 95ЊC for 15 s and 60ЊC for 1 min.
Nitric oxide detection. Nitric oxide levels in infected mac- Statistical analysis. The Student t test was used to compare two groups, whereas analysis of variance was used to compare multiple groups. Differences for which were considered P ! .05 to be statistically significant.
RESULTS

Intracellular yeast growth in resting versus GM-CSF-activated macrophages.
Elsewhere we reported that GM-CSF enhanced host defenses to H. capsulatum [9] . Hence, we sought to determine whether it would act on macrophages. The exposure of several populations of macrophages to GM-CSF inhibited the intracellular growth of H. capsulatum (Figure 1 ). IL-4 blunts immunity to H. capsulatum and is associated with the emergence of alternatively activated macrophages [10] . We asked whether pretreatment of macrophages with IL-4 would alter intracellular growth in activated macrophages [11] . We found that exposure of macrophages to IL-4 for 24 h enhanced yeast growth in BMD macrophages (Figure 1) .
We examined whether IL-4 alternatively activated infected macrophages. We assessed the expression levels of Arg1, Retnla, and Chi3l3 [12] . Each gene manifested enhanced expression following exposure of BMD macrophage cells to IL-4 and infection with H. capsulatum (Figure 2) . The abundance of another marker of IL-4 activation, transferrin receptor (TfR), was analyzed by flow cytometry. IL-4 treatment of macrophages 24 h before H. capsulatum infection did not increase total TfR expression levels as determined by the mean fluorescence intensity (MFI). The MFI of macrophages exposed to medium (926.6) did not differ from that of cells exposed to 10 ng/mL IL-4 (952.3). Moreover, no differences in the percentage of cells expressing TfR were observed between the two groups (data not shown). IL-4 did enhance TfR expression on uninfected cells in a dose-dependent manner. The MFI of cells exposed to medium only (2055.2) was less than that of cells exposed to IL-4 at a concentration of 0.1 ng/mL (3763.4), 1 ng/mL (4378.7), or 10 ng/mL (4333.9). Likewise, there was an increase in the percentage of cells expressing TfR; 79.5% of cells incubated in medium only were positive for TfR, whereas those values were 81.5%, 86.1%, and 88.1% for IL-4 concentrations of 0.1, 1, and 10 ng/mL, respectively.
We did not detect a statistically significant difference in the level of nitric oxide production between IL-4-treated macrophages ( mmol/L nitrite) and untreated macrophages 5.3 ‫ע‬ 0.2 ( mmol/L nitrite). 5.7 ‫ע‬ 0.4 GM-CSF regulates macrophage metal levels. We queried whether GM-CSF would alter metal levels in cells. We undertook an unbiased approach using ICPMS to assess levels of magnesium (Mg ) during infection of macrophages. We determined metal levels in uninfected and infected peritoneal macrophages and in those pretreated with GM-CSF [4] . Total metal concentrations were highest in resting uninfected peritoneal macrophages compared with those in all other populations (Table 2) . We observed decreases in the overall concentrations of metals upon infection, but this restriction was enhanced for total Fe and Zn 2+ by GM-CSF activation (Table  2) . GM-CSF did induce a decrease in Zn 2+ levels in uninfected peritoneal macrophages, but this was not statistically significant (Table 2) .
Macrophages from various organs may not regulate metals similarly; hence, Zn 2+ concentrations in BMD macrophages and alveolar macrophages were measured. Similar to infected peritoneal macrophages exposed to GM-CSF, infected BMD macrophages grown in the presence of GM-CSF yielded lower Zn 2+ and total Fe levels compared with those of infected resting peritoneal macrophages ( ) was mean p 3 sured in resting alveolar macrophages, whereas in GM-CSFtreated alveolar macrophages the Zn 2+ concentration was 124 ppb (RSD, 6%;
). The level of total Fe was 1200 ppb n p 3 (RSD, 1.9%; ) in resting alveolar macrophages, whereas n p 3 that in GM-CSF-treated alveolar macrophages was 540 ppb (RSD, 4%;
). n p 3 To ensure that the altered metal levels observed in this study were not a result of different numbers of yeasts initially ingested by the macrophages, we counted the number of yeasts within each cytokine-treated macrophage population. We observed that 1 h after infection, each macrophage population contained a mean ‫ע(‬ standard error of the mean) of yeasts. 12 ‫ע‬ 3 Moreover, using H. capsulatum that expressed green fluorescent protein, we found that ∼90% of macrophages were infected after 24 h.
We questioned whether our measurements of the overall cellular metal concentrations were acceptable. Reports estimate eukaryotic cell free cytosolic zinc levels to be in the ∼10
Ϫ12 mol/ L range, whereas total cellular zinc levels are ∼10 Ϫ4 mol/L; we measured a concentration of ∼10 Ϫ6 mol/L in ∼10 5 cells diluted in 50 mL of buffer [13] [14] [15] .
Metal levels within intracellular yeast cells. ( ) were detected in yeasts isolated from BMD macro-P ! .05 phages and GM-CSF-exposed peritoneal macrophages compared with those in resting peritoneal macrophages or H. capsulatum grown in culture alone (Table 2) .
To validate our method, we assessed whether IFN-g pretreatment of peritoneal macrophages decreased total Fe levels. A mean total Fe concentration of 2440 ppb (RSD, 7%; n p ) was detected in H. capsulatum cells isolated from IFN-g-3 pretreated peritoneal macrophages, compared with a mean total Fe concentration of 6240 ppb (RSD, 4%; ) detected in n p 3 resting peritoneal macrophages. Thus, these data support the utility of this method for assaying intracellular metal levels. IFN-g also decreased Zn 2+ levels. Cytokine-treated cells contained a mean Zn 2+ level of 600 ppb (RSD, 6%; ), and n p 3 resting cells contained a mean Zn 2+ level of 1900 ppb (RSD, 6%;
). n p 3 Increases in zinc levels in IL-4-treated macrophages and intracellular yeast cells. We asked whether IL-4 enhancement of fungal growth would be associated with a change in intracellular metal abundance levels. times inside infected BMD macrophages treated with IL-4, whereas total Fe concentrations did not increase (Table 2 ). In addition, higher Zn 2+ and Ca 2+ levels were detected in H. capsulatum cells isolated from IL-4-pretreated BMD macrophages compared with those detected in untreated cells (Table 2) .
Zinc influences yeast growth. A decrease of Zn 2+ levels in activated macrophages, coupled with an increase following IL-4 treatment, led us to hypothesize that restriction of Zn 2+ is a host defense mechanism against H. capsulatum infection. We sought to determine the effects of the Zn 2+ chelators DTPA and TPEN on H. capsulatum growth.
DTPA inhibited H. capsulatum growth in a dose-dependent manner in the presence and absence of peritoneal macrophages ( Figures 3A and 3B) . DTPA was not toxic at the concentrations used in this study. TPEN inhibited H. capsulatum growth in a dose-dependent manner in the presence and absence of peritoneal macrophages ( Figure 3C ). TPEN is toxic to macrophages at low concentrations; therefore, we could not adequately interpret the influence of TPEN on intracellular yeast growth.
Because Figure 3D ). GM-CSF regulation of macrophage zinc species. Zn 2+ is a cofactor and is required for numerous host processes [17] . We hypothesized that the changes in total Zn 2+ levels would need to be tightly regulated. Thus, we should detect a change in the total Zn 2+ binding species of GM-CSF-treated peritoneal macrophages and BMD macrophages compared with that in resting peritoneal macrophages. Figure 4 shows SEC chromatograms followed by ICPMS analysis representing the total Zn 2+ binding species of infected and uninfected resting peritoneal macrophages versus GM-CSF-treated peritoneal macrophages. A higher amount of Zn 2+ binding species was consistently detected in GM-CSF-treated peritoneal macrophages compared with that detected in resting peritoneal macrophages, especially Zn 2+ species eluting at 27 min.
Effect of GM-CSF is independent of modulation of calprotectin. Calprotectin has been shown to bind Zn 2+ and to possess antifungal activity [18] . We asked whether GM-CSF would alter the expression of calprotectin. Exposure of cells to GM-CSF did not statistically significantly increase the levels of calprotectin expression ( ; Student t test) ( Figure 5 Activation of murine macrophages with IFN-g stimulates the production of nitric oxide, which is believed to promote degradation of several intracellular pathogens including H. capsulatum [22] [23] [24] . Indirect and direct evidence also exists for IFN-g-mediated host restriction of total Fe availability [3, [25] [26] [27] . We detected lower levels of total Fe and Zn 2+ in IFN-gtreated macrophages and GM-CSF-treated macrophages. GM-CSF is a pleiotropic cytokine that induces myelopoiesis, acts as proinflammatory agent, and arms phagocytes to express antimicrobial activity [28] . Much of the literature indicates that GM-CSF enhances reactive oxygen intermediates as one mechanism of host defense. Our data reveal that another antimicrobial defense mechanism is the limitation of metals [29, 30] . We discovered that Zn 2+ levels were lower in GM-CSF-treated macrophages infected with H. capsulatum than those in resting infected macrophages.
Host intracellular Zn 2+ concentrations are controlled by Zn 2+ importers, exporters, and metal-binding proteins such as metallothionens [31] . Zn 2+ is an essential element required for mammalian cell function, but high concentrations of Zn 2+ can be toxic; therefore, regulation of this metal must be tightly controlled [32] . Thus, fluctuations in intracellular Zn 2+ levels must be initiated and/or responded to by the host. Accordingly, we detected changes in Zn 2+ species abundance to accompany GM-CSF-induced Zn 2+ restriction and IL-4-induced Zn 2+ replenishment. Thus, the changes in the number of Zn 2+ species add further support to the Zn 2+ level alterations detected. These data also suggest the participation of a host zinc regulatory mechanism influenced by different cytokines during H. capsulatum infection.
IL-4 alternatively activates macrophages and thereby inhibits the killing of intracellular and some extracellular organisms in vitro [11, 33, 34] . Overproduction of IL-4 under conditions of altered immunity accelerates H. capsulatum infection, but the mechanism remains unclear [10, 35, 36] . One mechanism through which IL-4 may contribute to organism survival during infection is by reducing nitric oxide production [37] , but in this study IL-4 reversal of GM-CSF activity was independent of nitric oxide production. Another potential mechanism of organism growth enhancement by IL-4 is the alteration of metal homeostasis. IL-4 increases Ca 2+ movement and accumulation in macrophages [38, 39] . Likewise, we detected increases in Ca 2+ levels in H. capsulatum cells isolated from IL-4-exposed macrophages. However, Ca 2+ chelation had only a minimal effect on intracellular yeast growth, thus suggesting that this metal is not important in the effect of IL-4. Treatment of macrophages with IL-4 has been suggested to make iron more available to Mycobacterium tuberculosis in macrophages [40] . In this study, increases in macrophage total Fe levels were not detected. In contrast, IL-4 treatment partially restored intracellular yeast growth and was associated with increased intracellular Zn 2+ levels. Thus, zinc rather than iron replenishment following IL-4 treatment of macrophages may contribute to a more permissive environment.
In summary, we have shown that cytokine-activated macrophages manifest a modulation of metal levels. The data support a crucial role for Zn 2+ limitation as a key element of host defenses against H. capsulatum infection.
